Prevalence of antineutrophil cytoplasmic antibodies in patients with various pulmonary diseases or multiorgan dysfunction

Arthritis Care and Research

Volumn 49, Issue 2, 2003, Pages 151-155

  Vassilopoulos, Dimitrios ^a   Niles, John L ^d   Villa Forte, Alexandra ^b   Arroliga, Alejandro C ^b   Sullivan, Eugene J ^b   Merkel, Peter A ^e   Hoffman, Gary S ^c  

^a HENRY DUNANT HOSPITAL   (Greece)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antineutrophil cytoplasmic antibodies; Multiorgan dysfunction; Systemic vasculitis

Indexed keywords

MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOFLUORESCENCE; IMMUNOPATHOGENESIS; LUNG INSUFFICIENCY; MAJOR CLINICAL STUDY; MULTIPLE ORGAN FAILURE; WEGENER GRANULOMATOSIS;

EID: 0037446513     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10997     Document Type: Article

References (21)

1. Hoffman GS, Specks U. Antineutrophil cytoplasmic antibodies. Arthritis Rheum 1998;41:1521-37.
2. Franssen CF, Stegeman CA, Kallenberg CG, Gans RO, De Jong PE, Hoorntje SJ, et al. Antiproteinase 3- and antimyeloperoxidase-associated vasculitis. Kidney Int 2000;57:2195-206.
3. Niles JL, Pan GL, Collins AB, Shannon T, Skates S, Fienberg R, et al. Antigen-specific radioimmunoassays for anti-neutrophil cytoplasmic antibodies in the diagnosis of rapidly progressive glomerulonephritis. J Am Soc Nephrol 1991;2:27-36.
4. Falk RJ, Nachman PH, Hogan SL, Jennette JC. ANCA glomerulonephritis and vasculitis: a Chapel Hill perspective. Semin Nephrol 2000;20:233-43.
5. Merkel PA, Polisson RP, Chang Y, Skates SJ, Niles JL. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med 1997;126:866-73.
6. Hagen EC, Daha MR, Hermans J, Andrassy K, Csernok E, Gaskin G, et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int 1998;53:743-53.
7. Vassilopoulos D, Hoffman GS. Clinical utility of testing for antineutrophil cytoplasmic antibodies. Clin Diagn Lab Immunol 1999;6:645-51.
8. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 1995;23:1638-52.
9. Leavitt RY, Fauci AS, Block DA, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 Criteria for the Classification of Wegener's granulomatosis. Arthritis Rheum 1990;33:1101-7.
10. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides: the proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
11. Rao JK, Weinberger M, Oddone EZ, Allen NB, Landsman P, Feussner JR. The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis: a literature review and meta-analysis. Ann Intern Med 1995;123:925-32.
12. Ter Maaten JC, Franssen CF, Gans RO, van Schijndel RJ, Hoorntje SJ. Respiratory failure in ANCA-associated vasculitis. Chest 1996;110:357-62.
13. Niles JL, Bottinger EP, Saurina GR, Kelly KJ, Pan G, Collins AB, et al. The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition. Arch Intern Med 1996;156:440-5.
14. Westman KW, Bygren PG, Eilert I, Wiik A, Wieslander J. Rapid screening assay for anti-GBM antibody and ANCAs; an important tool for the differential diagnosis of pulmonary renal syndromes. Nephrol Dial Transplant 1997;12:1863-8.
15. Saxena R, Bygren P, Arvastson B, Wieslander J. Circulating autoantibodies as serological markers in the differential diagnosis of pulmonary renal syndrome. J Intern Med 1995;238:143-52.
16. Ardiles LG, Valderrama G, Moya P, Mezzano SA. Incidence and studies on antigenic specificities of antineutrophil-cytoplasmic autoantibodies (ANCA) in poststreptococcal glomerulonephritis. Clin Nephrol 1997;47:1-5.
17. Lamprecht P, Gadola S, Schnabel A, Gross WL, ANCA, infectious endocarditis, glomerulonephritis and cryoglobulinemic vasculitis. Clin Nephrol 1998;49:389-90.
18. Choi HK, Merkel PA, Walker AM, Niles JL. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum 2000;43:405-13.
19. Choi HK, Lamprecht P, Niles JL, Gross WL, Merkel PA. Subacute bacterial endocarditis with positive cytoplasmic antineutrophil cytoplasmic antibodies and anti-proteinase 3 antibodies. Arthritis Rheum 2000;43:226-31.
20. Yahya TM, Benedict S, Shalabi A, Bayoumi R. Anti-neutrophil cytoplasmic antibody (ANCA) in malaria is directed against cathepsin G. Clin Exp Immunol 1997;110:41-4.
21. Cho C, Asuncion A, Tatum AH. False-positive antineutrophil cytoplasmic antibody in aspergillosis with oxalosis. Arch Pathol Lab Med 1995;119:558-61.